Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Armstrong

Showing results (781-790 of 1,035) with videos related to

Pageof 104
Sort By:
Journal of Neurophysiology|February 1, 2018
Three members of a peptide family are differentially distributed and elicit differential state-dependent responses in a pattern generator-effector systemPatsy S Dickinson, Matthew K Armstrong, Evyn S Dickinson, et al.
Pediatric Cardiology|May 7, 2023
Patch Materials for Pulmonary Artery Arterioplasty and Right Ventricular Outflow Tract Augmentation: A ReviewWilliam E Schwartzman, Michael Jimenez, Andrew R Yates, et al.
Military Medicine|September 23, 2025
A Novel, Reverse-Phase-Shifting, Thermoreversible Foaming Hydrogel Containing Antibiotics for the Treatment of Traumatic Tissue Injuries in a Swine ModelRoss I Donaldson, Aslam A Akhtar, Arghavan Farzadi, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|August 16, 2023
3-year follow-up of a prospective, multicenter study of the Amplatzer Piccolo™ Occluder for transcatheter patent ductus arteriosus closure in children ≥ 700 gramsBrian H Morray, Shyam K Sathanandam, Thomas Forbes, et al.
Cancer Chemotherapy and Pharmacology|November 17, 2001
Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumorsE I Heath, S O'Reilly, R Humphrey, et al.
Journal of Exposure Science & Environmental Epidemiology|May 22, 2008
Recall bias in the assessment of exposure to mobile phonesMartine Vrijheid, Bruce K Armstrong, Daniel Bédard, et al.
Gynecologic Oncology|November 19, 2013
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paperThomas J Herzog, Deborah K Armstrong, Mark F Brady, et al.
Cancer Causes & Control : CCC|January 18, 2006
Pregnancy history and incidence of melanoma in women: a pooled analysisMargaret R Karagas, Michael S Zens, Therese A Stukel, et al.
Gynecologic Oncology|November 1, 2011
A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a gynecologic oncology group studyAgustin A Garcia, Michael W Sill, Heather A Lankes, et al.
Gynecologic Oncology|June 21, 2011
The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: a Gynecologic Oncology Group studyChad A Hamilton, Austin Miller, Caela Miller, et al.
Pageof 104

Showing results (781-790 of 1,035) with videos related to

Sort By:
Pageof 104
Journal of Neurophysiology|February 1, 2018
Three members of a peptide family are differentially distributed and elicit differential state-dependent responses in a pattern generator-effector systemPatsy S Dickinson, Matthew K Armstrong, Evyn S Dickinson, et al.
Pediatric Cardiology|May 7, 2023
Patch Materials for Pulmonary Artery Arterioplasty and Right Ventricular Outflow Tract Augmentation: A ReviewWilliam E Schwartzman, Michael Jimenez, Andrew R Yates, et al.
Military Medicine|September 23, 2025
A Novel, Reverse-Phase-Shifting, Thermoreversible Foaming Hydrogel Containing Antibiotics for the Treatment of Traumatic Tissue Injuries in a Swine ModelRoss I Donaldson, Aslam A Akhtar, Arghavan Farzadi, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|August 16, 2023
3-year follow-up of a prospective, multicenter study of the Amplatzer Piccolo™ Occluder for transcatheter patent ductus arteriosus closure in children ≥ 700 gramsBrian H Morray, Shyam K Sathanandam, Thomas Forbes, et al.
Cancer Chemotherapy and Pharmacology|November 17, 2001
Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumorsE I Heath, S O'Reilly, R Humphrey, et al.
Journal of Exposure Science & Environmental Epidemiology|May 22, 2008
Recall bias in the assessment of exposure to mobile phonesMartine Vrijheid, Bruce K Armstrong, Daniel Bédard, et al.
Gynecologic Oncology|November 19, 2013
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paperThomas J Herzog, Deborah K Armstrong, Mark F Brady, et al.
Cancer Causes & Control : CCC|January 18, 2006
Pregnancy history and incidence of melanoma in women: a pooled analysisMargaret R Karagas, Michael S Zens, Therese A Stukel, et al.
Gynecologic Oncology|November 1, 2011
A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a gynecologic oncology group studyAgustin A Garcia, Michael W Sill, Heather A Lankes, et al.
Gynecologic Oncology|June 21, 2011
The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: a Gynecologic Oncology Group studyChad A Hamilton, Austin Miller, Caela Miller, et al.
Pageof 104